$0.47
ProPhase Labs


Performance
Dividends
1W
1M
YTD
1Y
3Y
19/36
Growth
Score
14/36
Dividend
Score
Valuation
PE Ratio
-0.38
PS Ratio
4.24
RSI
-
3
PEG Ratio
0.01
0
PRG Ratio
0
PDG Ratio
0
Growth
2023
2024
2025*
2026*
3
Revenue
Revenue
*Analyst estimated growth
Fundamentals
3
Rule
of 40
81.76%
0
Gross Margin
17.71%
1
Current Ratio
1.03
Return on Assets
-86.07%
Return on Equity
-164.83%
Return on inv. Capital
-133.96%
Institutional Holder
Shares
Holders
Financials
Yealy
Quarterly
Revenue 2024 6.77M
2018
2019
2020
2021
2022
2023
2024
6
Net Income 2024 -49.52M
2018
2019
2020
2021
2022
2023
2024
6
Gross Profit 2024 -150.000
2018
2019
2020
2021
2022
2023
2024
6
Events

PRPH
ProPhase Labs
in 277 days
before market open
Earnings per Share is expected with - and revenue with - .

PRPH
ProPhase Labs
in 228 days
before market open
Earnings per Share is expected with - and revenue with - .

PRPH
ProPhase Labs
in 89 days
before market open
Earnings per Share is expected with - and revenue with - .
About
Sector/Industry
Healthcare
Drug Manufacturers - Specialty & Generic
IPO Date
04.04.1994
MaketCap
19.36M
Country
US
CEO
Ted William Karkus
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.
Updated 28.07.2025